Company Filing History:
2 out of 24 
2 out of 5,094 
2 out of 1,745 
Years Active: 2017-2018
Title: Maite Noizet: Innovator in Fibrosis Treatment
Introduction
Maite Noizet is a prominent inventor based in Versailles, France. She has made significant contributions to the field of medical research, particularly in the prevention and treatment of fibrosis, hypertrophic scars, and keloids. Her innovative work has led to the development of a therapeutic compound that targets specific genes associated with these conditions.
Latest Patents
Maite Noizet holds a patent for her invention titled "Molecular targets for the prevention and/or treatment of fibrosis, hypertrophic scars or keloids." This patent encompasses a therapeutic compound that includes an agent inhibiting the activity of genes such as HIC1, FOXS1, CREB5, IRF7, POU2F2, STAT4, and TCF4. Additionally, it features an agent that enhances the activity of genes like MAF, MEOX2, and SIX2. This innovative approach has the potential to revolutionize treatment options for patients suffering from these conditions. She has 1 patent to her name.
Career Highlights
Throughout her career, Maite Noizet has worked with esteemed organizations, including the Centre National de la Recherche Scientifique and the Institut National de la Santé et de la Recherche Médicale. Her dedication to research and innovation has positioned her as a key figure in her field.
Collaborations
Maite has collaborated with notable colleagues, including Claire Dugast-Darzacq and Xavier Darzacq. These partnerships have further enhanced her research and contributed to her success as an inventor.
Conclusion
Maite Noizet's contributions to the field of fibrosis treatment exemplify her commitment to medical innovation. Her groundbreaking patent and collaborations highlight her role as a leading inventor in this important area of research.